静脈瘤治療装置の世界市場:種類別(静脈内切除、硬化療法、外科的結紮・剥離)、地域別、セグメント予測

◆英語タイトル:Varicose Veins Treatment Devices Market Size, Share & Trends Analysis Report By Type (Endovenous Ablation, Sclerotherapy, Surgical Ligation & Stripping), By Region, And Segment Forecasts, 2019 - 2025
◆商品コード:GVW903175
◆発行会社(リサーチ会社):Grand View Research
◆発行日:2019年2月28日
◆ページ数:120
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD4,950 ⇒換算¥514,800見積依頼/購入/質問フォーム
Multi UserUSD5,950 ⇒換算¥618,800見積依頼/購入/質問フォーム
Global/corporate LicenseUSD7,950 ⇒換算¥826,800見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Grand View Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、静脈瘤治療装置の世界市場について調査・分析し、静脈瘤治療装置の世界市場動向、静脈瘤治療装置の世界市場規模、市場予測、セグメント別静脈瘤治療装置市場分析、主要地域別市場規模、競争状況、関連企業情報などを含め、以下の構成でお届け致します。
【レポートの概要】

The global varicose veins treatment devices market is expected to reach USD 1.7 billion by 2025, according to a new report by Grand View Research, Inc. It is anticipated to register a CAGR of 6.3% during the forecast period. Rising investments by the key healthcare companies to develop innovative and effective products is likely to drive the growth.
Varicose veins can be unsightly and can lead to considerable discomfort in some cases. Available treatments for varicose veins have improved since the last few years. Various healthcare providers are offering minimally invasive techniques such as radiofrequency ablation and laser therapies. Due to the risk of infections associated with invasive surgeries, surgical vein stripping methods have been replaced by noninvasive procedures. Sclerotherapy is the most popular procedure and is used as a first-line of treatment among endovenous ablation and surgical stripping.

North America held the leading market share in terms of revenue in 2018 due to technological advancements and the fact that about 30 million Americans suffer from varicose vein each year. In U.S., Medicare provides coverage to the patients undergoing sclerotherapy treatment for varicose veins, which can increase its adoption by the care providers and especially by the patients.

Some market players purchase products from core manufacturers and distribute. For instance, AngioDynamics, Inc. purchased Asclera from Merz in March 2016. AngioDynamics announced that it has entered into an agreement with Merz North America, a part of the global Merz Pharma Group, for the distribution of Asclera injection within U.S. In another development, Medtronic announced that the new CPT codes may aid in getting positive coverage for its VenaSeal closure device from the public and private insurers in U.S. in November 2017.

Development of innovative products, commercialization, and availability of reimbursements are some of the strategies undertaken by the market players to strengthen their position in the varicose veins treatment devices market. In May 2016, Navarro opened a vein center in U.S. with a vision to educate the community about chronic venous insufficiency and varicose veins and the proper treatment options.

Further key findings from the report suggest:

• Sclerotherapy segment led the market in 2018 due to the advantages of this treatment such as no scarring; no need for anesthesia; no need for hospital admission; simple follow-up treatments; and favorable reimbursement policies

• Endovenous ablation segment is anticipated to witness the fastest growth over the forecast period as this treatment is preferred over the conventional procedures such as surgical stripping and ligation

• Asia Pacific is expected to be the fastest growing region in the forthcoming years due to rising awareness about minimally invasive and noninvasive procedures, rising disposable income levels, and a large base of geriatric population

• Some of the key players operating in the varicose veins treatment devices market are AngioDynamics, Inc.; Medtronic plc; Syneron Medical Ltd.; Biolitec AG; Lumenis Ltd.; Energist Group; Eufoton srl; and Teleflex, Inc.

• In addition, market players acquire other vascular businesses to boost their own product portfolio and overall revenue. For instance, Teleflex acquired Vascular Solutions, Inc. in 2017.

【レポートの目次】

Table of Contents

Chapter 1 Research Methodology
1.1 Market Segmentation & Scope
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.4 Information Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Data Visualization
1.6 Model Details
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
Chapter 3 Market Variables, Trends & Scope
3.1 Market Segmentation
3.1.1 Market Driver Analysis
3.1.1.1 Growing preference for minimally invasive treatment procedures
3.1.1.2 Introduction of technologically advanced devices
3.1.1.3 Increasing geriatric population
3.1.2 Market Restraint Analysis
3.1.2.1 High procedural costs and inconsistent reimbursement structure
3.1.2.2 Risk factors associated with varicose veins treatment
3.2 Penetration & Growth Prospects Mapping
3.3 Varicose Vein Treatment Devices Market – PESTLE Analysis
3.4 Industry Analysis – Porter’s Five Forces Analysis
3.5 Varicose Vein Treatment Market, by Therapy Type
3.6 Patient Population
3.6.1 Female vs. Male Population
3.6.2 Geriatric vs. Adult Population
3.7 Reimbursement Scenario
3.8 Spider Veins: Treatment Scenario
3.9 Varicose Vein Treatment: Future Trends
3.9.1 VenaSeal Closure System
3.9.2 Varithena
Chapter 4 Varicose Vein Treatment Devices: Type Estimates & Trend Analysis
4.1 Varicose Vein Treatment Devices Market: Type Movement Analysis
4.2 Endovenous Ablation (EVLA)
4.2.1 Endovenous Ablation Market, 2014 – 2025 (USD Million)
4.2.2 Radiofrequency Ablation
4.2.2.1 Radiofrequency ablation market, 2014 – 2025 (USD Million)
4.2.3 Laser Ablation
4.2.3.1 Laser ablation market, 2014 – 2025 (USD Million)
4.3 Sclerotherapy
4.3.1 Sclerotherapy Market, 2014 – 2025 (USD Million)
4.4 Surgical Ligation & Stripping
4.4.1 Surgical Ligation & Stripping Market, 2014 – 2025 (USD Million)
Chapter 5 Varicose Vein Treatment Devices: Regional Estimates & Trend Analysis, by Type
5.1 Varicose Vein Treatment Devices Market Share by Region, 2018 & 2025
5.2 North America
5.2.1 North America Varicose Vein Treatment Devices Market, 2014 – 2025 (USD Million)
5.2.2 U.S.
5.2.2.1 U.S. varicose vein treatment devices market, 2014 – 2025 (USD Million)
5.2.3 Canada
5.2.3.1 Canada varicose vein treatment devices market, 2014 – 2025 (USD Million)
5.3 Europe
5.3.1 Europe Varicose Vein Treatment Devices Market, 2014 – 2025 (USD Million)
5.3.2 U.K.
5.3.2.1 U.K. varicose vein treatment devices market, 2014 – 2025 (USD Million)
5.3.3 France
5.3.3.1 France varicose vein treatment devices market, 2014 – 2025 (USD Million)
5.3.4 Germany
5.3.4.1 Germany varicose vein treatment devices market, 2014 – 2025 (USD Million)
5.4 Asia Pacific
5.4.1 Asia Pacific Varicose Vein Treatment Devices Market, 2014 – 2025 (USD Million)
5.4.2 India
5.4.2.1 India varicose vein treatment devices market, 2014 – 2025 (USD Million)
5.4.3 China
5.4.3.1 China varicose vein treatment devices market, 2014 – 2025 (USD Million)
5.4.4 Japan
5.4.4.1 Japan varicose vein treatment devices market, 2014 – 2025 (USD Million)
5.5 Latin America
5.5.1 Latin America Varicose Vein Treatment Devices Market, 2014 – 2025 (USD Million)
5.5.2 Brazil
5.5.2.1 Brazil varicose vein treatment devices market, 2014 – 2025 (USD Million)
5.5.3 Mexico
5.5.3.1 Mexico varicose vein treatment devices market, 2014 – 2025 (USD Million)
5.6 MEA
5.6.1 MEA Varicose Vein Treatment Devices Market, 2014 – 2025 (USD Million)
5.6.2 South Africa
5.6.2.1 South Africa varicose vein treatment devices market, 2014 – 2025 (USD Million)
Chapter 6 Competitive Landscape
6.1 Recent Developments & Impact Analysis, By Key Market Participants
6.2 Company/Competition Categorization
6.3 Public Companies
6.3.1 Company Market Position Analysis (Revenue, Geographic Presence, Product Portfolio, Key Serviceable Industries, Key Alliances)
6.3.2 Competitive Dashboard Analysis
6.3.2.1 Market differentiators
6.3.2.2 Synergy analysis: Major deals & strategic alliances
6.4 Private Companies
6.4.1 List Of Key Emerging Companies/Technology Disruptors/Innovators
6.4.2 Company Market Position Analysis (Geographic Presence, Product Portfolio, Key Alliance, Industry Experience)
6.5 Strategy Framework
6.6 Company Profiles
6.6.1 Medtronic
6.6.1.1 Company overview
6.6.1.2 Financial performance
6.6.1.3 Strategic initiatives
6.6.2 AngioDynamics, Inc.
6.6.2.1 Company overview
6.6.2.2 Financial performance
6.6.2.3 Product benchmarking
6.6.2.4 Strategic initiatives
6.6.3 biolitec AG
6.6.3.1 Company overview
6.6.3.2 Product benchmarking
6.6.3.3 Product benchmarking
6.6.4 Syneron Medical Ltd.
6.6.4.1 Company overview
6.6.4.2 Financial performance
6.6.4.3 Product benchmarking
6.6.4.4 Strategic initiatives
6.6.5 Lumenis
6.6.5.1 Company overview
6.6.5.2 Financial performance
6.6.5.3 Product benchmarking
6.6.5.4 Strategic initiatives
6.6.6 Energist Ltd.
6.6.6.1 Company overview
6.6.6.2 Product benchmarking
6.6.6.3 Strategic initiatives
6.6.7 Eufoton s.r.l.
6.6.7.1 Company overview
6.6.7.2 Product benchmarking
6.6.8 Teleflex Incorporated
6.6.8.1 Company overview
6.6.8.2 Financial performance
6.6.8.3 Product benchmarking
6.6.8.4 Strategic initiatives
6.6.9 Quanta System
6.6.9.1 Company overview
6.6.9.2 Product benchmarking
6.6.9.3 Strategic initiatives
Chapter 7 Recommendations

List of Tables

TABLE 1 Varicose vein treatment scenario in the U.S.: Female vs. male population (2016)
TABLE 2 Sclerotherapy reimbursement codes in the U.S.
TABLE 3 Sclerotherapy reimbursement codes in Canada
TABLE 4 Vein clinics in Mid-Atlantic Region (U.S.)
TABLE 5 Vein clinics s in Mid-West Region (U.S.)
TABLE 6 Vein clinics in North-East Region (U.S.)
TABLE 7 Vein clinics in North-West Region (U.S.)
TABLE 8 Vein clinics in South-East Region (U.S.)
TABLE 9 Vein clinics in South-West Region (U.S.)
TABLE 10 Ongoing clinical trials
TABLE 11 Reimbursement codes for endovenous ablation
TABLE 12 Reimbursement codes for sclerotherapy
TABLE 13 Reimbursement codes for stripping and ligation
TABLE 14 North America varicose vein treatment devices market, by country, 2014 - 2025 (USD Million)
TABLE 15 North America varicose vein treatment devices market, by type, 2014 - 2025 (USD Million)
TABLE 16 North America endovenous ablation devices market, by type, 2014 - 2025 (USD Million)
TABLE 17 CEAP classification of severity of varicose veins
TABLE 18 U.S. varicose vein treatment devices market, by type, 2014 - 2025 (USD Million)
TABLE 19 U.S. endovenous ablation devices market, by type, 2014 - 2025 (USD Million)
TABLE 20 Canada varicose vein treatment devices market, by type, 2014 - 2025 (USD Million)
TABLE 21 Canada endovenous ablation devices market, by type, 2014 - 2025 (USD Million)
TABLE 22 Europe varicose vein treatment devices market, by region, 2014 - 2025 (USD Million)
TABLE 23 Europe varicose vein treatment devices market, by type, 2014 - 2025 (USD Million)
TABLE 24 Europe endovenous ablation devices market, by type, 2014 - 2025 (USD Million)
TABLE 25 U.K. varicose vein treatment devices market, by type, 2014 - 2025 (USD Million)
TABLE 26 U.K. endovenous ablation devices market, by type, 2014 - 2025 (USD Million)
TABLE 27 France varicose vein treatment devices market, by type, 2014 - 2025 (USD Million)
TABLE 28 France endovenous ablation devices market, by type, 2014 - 2025 (USD Million)
TABLE 29 Germany varicose vein treatment devices market, by type, 2014 - 2025 (USD Million)
TABLE 30 Germany endovenous ablation devices market, by type, 2014 - 2025 (USD Million)
TABLE 31 Asia Pacific varicose vein treatment devices market, by region, 2014 - 2025 (USD Million)
TABLE 32 Asia Pacific varicose vein treatment devices market, by type, 2014 - 2025 (USD Million)
TABLE 33 Asia Pacific endovenous ablation devices market, by type, 2014 - 2025 (USD Million)
TABLE 34 India varicose vein treatment devices market, by type, 2014 - 2025 (USD Million)
TABLE 35 India endovenous ablation devices market, by type, 2014 - 2025 (USD Million)
TABLE 36 China varicose vein treatment devices market, by type, 2014 - 2025 (USD Million)
TABLE 37 China endovenous ablation devices market, by type, 2014 - 2025 (USD Million)
TABLE 38 Japan varicose vein treatment devices market, by type, 2014 - 2025 (USD Million)
TABLE 39 Japan endovenous ablation devices market, by type, 2014 - 2025 (USD Million)
TABLE 40 Latin America varicose vein treatment devices market, by region, 2014 - 2025 (USD Million)
TABLE 41 Latin America varicose vein treatment devices market, by type, 2014 - 2025 (USD Million)
TABLE 42 Latin America endovenous ablation devices market, by type, 2014 - 2025 (USD Million)
TABLE 43 Brazil varicose vein treatment devices market, by type, 2014 - 2025 (USD Million)
TABLE 44 Brazil endovenous ablation devices market, by type, 2014 - 2025 (USD Million)
TABLE 45 Mexico varicose vein treatment devices market, by type, 2014 - 2025 (USD Million)
TABLE 46 Mexico endovenous ablation devices market, by type, 2014 - 2025 (USD Million)
TABLE 47 MEA varicose vein treatment devices market, by region, 2014 - 2025 (USD Million)
TABLE 48 MEA varicose vein treatment devices market, by type, 2014 - 2025 (USD Million)
TABLE 49 MEA endovenous ablation devices market, by type, 2014 - 2025 (USD Million)
TABLE 50 South Africa varicose vein treatment devices market, by type, 2014 - 2025 (USD Million)
TABLE 51 South Africa endovenous ablation devices market, by type, 2014 - 2025 (USD Million)


List of Figures

FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain based sizing & forecasting
FIG. 6 QFD modeling for market share assessment
FIG. 7 Market summary, 2018
FIG. 8 Market trends & outlook
FIG. 9 Market segmentation & scope
FIG. 10 Market driver relevance analysis (Current & future impact)
FIG. 11 Strong preference for non-invasive procedures (In Million)
FIG. 12 Percentage distribution of population aged 65 and over by region: 2015 and 2050
FIG. 13 Expected geriatric population in the U.S., 2012 - 2050 (Million)
FIG. 14 Market restraint relevance analysis (Current & future impact)
FIG. 15 Penetration & growth prospect mapping
FIG. 16 Varicose vein treatment devices market - PESTLE analysis
FIG. 17 Porter’s Five Forces Analysis
FIG. 18 Varicose vein treatment devices market share, 2018
FIG. 19 Varicose vein treatment: Female vs. male population
FIG. 20 Varicose vein treatment scenario: Age group
FIG. 21 Varicose vein treatment devices market type outlook key takeaways
FIG. 22 Varicose vein treatment devices market: Type movement analysis
FIG. 23 Global endovenous ablation market, 2014 - 2025 (USD Million)
FIG. 24 Global radio frequency ablation market, 2014 - 2025 (USD Million)
FIG. 25 Percentage of patients with complications
FIG. 26 Global laser ablation market, 2014 - 2025 (USD Million)
FIG. 27 Global sclerotherapy market, 2014 - 2025 (USD Million)
FIG. 28 Global surgical ligation & stripping market, 2014 - 2025 (USD Million)
FIG. 29 Regional market place: Key takeaways
FIG. 30 Regional outlook, 2018 & 2025
FIG. 31 North America varicose vein treatment devices market, 2014 - 2025 (USD Million)
FIG. 32 U.S. varicose vein treatment devices market, 2014 - 2025 (USD Million)
FIG. 33 Canada varicose vein treatment devices market, 2014 - 2025 (USD Million)
FIG. 34 Europe varicose vein treatment devices market, 2014 - 2025 (USD Million)
FIG. 35 U.K. varicose vein treatment devices market, 2014 - 2025 (USD Million)
FIG. 36 France varicose vein treatment devices market, 2014 - 2025 (USD Million)
FIG. 37 Germany varicose vein treatment devices market, 2014 - 2025 (USD Million)
FIG. 38 Asia Pacific varicose vein treatment devices market, 2014 - 2025 (USD Million)
FIG. 39 India varicose vein treatment devices market, 2014 - 2025 (USD Million)
FIG. 40 China varicose vein treatment devices market, 2014 - 2025 (USD Million)
FIG. 41 Japan varicose vein treatment devices market, 2014 - 2025 (USD Million)
FIG. 42 Latin America varicose vein treatment devices market, 2014 - 2025 (USD Million)
FIG. 43 Brazil varicose vein treatment devices market, 2014 - 2025 (USD Million)
FIG. 44 Mexico varicose vein treatment devices market, 2014 - 2025 (USD Million)
FIG. 45 MEA varicose vein treatment devices market, 2014 - 2025 (USD Million)
FIG. 46 South Africa varicose vein treatment devices market, 2014 - 2025 (USD Million)
FIG. 47 Strategy framework
FIG. 48 Varicose vein treatment devices competitive landscape: Market position analysis (based on products, regional presence, and recent updates (2018))

【掲載企業】

Medtronic、AngioDynamics, Inc.、biolitec AG、Syneron Medical Ltd.、Lumenis、Energist Ltd.、Eufoton s.r.l.、Teleflex Incorporated、Quanta System

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[静脈瘤治療装置の世界市場:種類別(静脈内切除、硬化療法、外科的結紮・剥離)、地域別、セグメント予測]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆